Dr. Au is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2800 L St
Suite 500
Sacramento, CA 95816Phone+1 916-454-6850Fax+1 916-454-6852
Summary
- Major interest in Alzheimer's disease and related dementias and Multiple Sclerosis
Education & Training
- University of California Davis HealthResidency, Neurology, 1976 - 1979
- Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 1975 - 1976
- University of California, Irvine, School of MedicineClass of 1975
Certifications & Licensure
- CA State Medical License 1976 - 2026
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Golden Stethoscope Award SSVMS, 2010
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsFive-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease.Shawn Kile, William Au, Carol Parise, Kimberley Rose, Tammy Donnel
BMC Neuroscience. 2021-08-01 - 8 citationsReduction of Amyloid in the Brain and Retina After Treatment With IVIG for Mild Cognitive Impairment.Shawn Kile, William Au, Carol Parise, Jaideep Sohi, Tracy Yarbrough
American Journal of Alzheimer's Disease and Other Dementias. 2020-02-12 - 327 citationsRetinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s diseaseYosef Koronyo, David Biggs, Ernesto Barron, David S. Boyer, Joel A. Pearlman
JCI Insight. 2017-08-17
Journal Articles
- Reduction of amyloid in the brain and retina after treatment with IVIG form mild cognitive impairmentKile, Au et al, American Journal of Alzheimer's disease and Other Dementias, 2/2020
- Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's diseaseKile, Au et al, Journal of clinical Investigation, 8/2017
- Alleviating flu-like symptoms with dose titration and analgesics in MS patients on intramuscular Interferon beta-1a therapy: a pilot studyBrandes, Au et al, Current Medical Research and Opinion, 2007
- Join now to see all
Abstracts/Posters
- Initial findings of a randomized double-blinded placebo-controlled study of IVIG in Mild cognitive Impairment due to Alzheimer DiseaseAu, Kile et al, American Academy of Neurology annual conference, 3/2013
- Management of Flu-Like symptoms in Relapsing MS patients at Initiation of Avonex therapyBrandes, Au et al, Consortium of MS Centers, Toronto, Canada, 6/2004
Research History
- PI and sub-I in Multi-center trial past and currentPI 28 clinical trials primarily in AD and related dementias and MS sub-I 14 clinical trials1991 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: